Invention Grant
- Patent Title: Human antibodies binding to RSV G protein
-
Application No.: US14784937Application Date: 2014-04-14
-
Publication No.: US10196438B2Publication Date: 2019-02-05
- Inventor: Jehangir Wadia , Robert Anthony Williamson , Johannes P. M. Langedijk , Gabriel Pascual , Angelique Van 'T Wout
- Applicant: Crucell Holland B.V.
- Applicant Address: NL Leiden
- Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee: Janssen Vaccines & Prevention B.V.
- Current Assignee Address: NL Leiden
- Agency: Kramer Amado P.C.
- Priority: EP13179241 20130805
- International Application: PCT/EP2014/057499 WO 20140414
- International Announcement: WO2014/170257 WO 20141023
- Main IPC: C07K14/115
- IPC: C07K14/115 ; A61K39/155 ; A61K39/145 ; C07K14/005 ; C07K16/10 ; G01N33/569 ; A61K47/68 ; A61K39/00
Abstract:
The disclosure relates to isolated antibodies and antigen-binding fragments that bind to the G protein of RSV and which are capable of neutralizing RSV A and B subtypes, and the use thereof in the diagnosis, prophylaxis, and/or treatment of RSV infections.
Public/Granted literature
- US20160145321A1 HUMAN ANTIBODIES BINDING TO RSV G PROTEIN Public/Granted day:2016-05-26
Information query
